|
---|
Category:Legal-Exhibit
MONTHYEARML16021A1952015-12-29029 December 2015 Official Exhibit - NRC-002-R-MA-CM01 - Shine Medical Technologies, Inc., Medical Isotope Production Facility Draft Construction Permit ML16021A1942015-12-29029 December 2015 Official Exhibit - NRC-014-MA-CM01 - NRC Staff Responses to Post-Hearing Questions ML16021A1932015-12-22022 December 2015 Official Exhibit - SHN-030-MA-CM01 - Shine Response to Commission Post Hearing Questions ML15351A2812015-12-15015 December 2015 Official Exhibit - SHN-026-MA-CM01 - Shine Overview Panel Presentation ML15351A2822015-12-15015 December 2015 Official Exhibit - SHN-027-MA-CM01 - Shine Presentation Slides: Safety Panel 1 ML15351A2842015-12-15015 December 2015 Official Exhibit - SHN-028-MA-CM01 - Shine Presentation Slides: Safety Panel 2 ML15351A2512015-12-11011 December 2015 Official Exhibit - NRC-012-R-MA-CM01 - Staff Presentation Slides - Safety Panel 2 (December 8, 2015, Corrected Exhibit Filed December 11, 2015) ML15351A2492015-12-0808 December 2015 Official Exhibit - NRC-006R-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - Environmental Report, (PSAR) Chapter 19, Figure 19.5.2-6 Through Figure 19.5.2-9 (August 27, 2015) ML15351A2242015-12-0808 December 2015 Official Exhibit - NRC-004-R-MA-CM01 - NRC Staff Responses to Commission Pre-Hearing Questions, (Originally Filed on November 24, 2015), (Revised December 8, 2015) ML15351A2372015-12-0808 December 2015 Official Exhibit - NRC-006L-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - Environmental Report, (PSAR) Chapter 19, Figure 19.3.2-1 Through Figure 19.3.2-36 (August 27, 2015) ML15351A2302015-12-0808 December 2015 Official Exhibit - NRC-008-MA-CM01 - Safety Evaluation Report Related to Shine Medical Technologies, Inc. Construction Permit Application for a Medial Radioisotope Production Facility, (Revised December 8, 2015) ML15351A2272015-12-0808 December 2015 Official Exhibit - NRC-002-MA-CM01 - Draft Construction Permit for Shine Medical Technologies, Inc. (December 8, 2015) ML15351A2532015-12-0808 December 2015 Official Exhibit - SHN-002-MA-CM01 - Shine Medical Technologies, Inc.'S Responses to Commission'S Public Pre-Hearing Questions ML15351A2552015-12-0808 December 2015 Official Exhibit - SHN-004-MA-CM01 - Statement of Qualifications of Joseph M. Aldieri ML15351A2562015-12-0808 December 2015 Official Exhibit - SHN-005-MA-CM01 - Statement of Qualifications of Jeffrey M. Bartelme ML15351A2572015-12-0808 December 2015 Official Exhibit - SHN-014-MA-CM01 - Statement of Qualifications of James W. Mcintyre ML15351A2582015-12-0808 December 2015 Official Exhibit - SHN-015-MA-CM01 - Statement of Qualifications of John B. Mclean ML15351A2592015-12-0808 December 2015 Official Exhibit - SHN-016-MA-CM01 - Statement of Qualifications of William D. Newmyer ML15351A2602015-12-0808 December 2015 Official Exhibit - SHN-017-MA-CM01 - Statement of Qualifications of Greg Piefer ML15351A2622015-12-0808 December 2015 Official Exhibit - SHN-018-MA-CM01 - Statement of Qualifications of Katrina M. Pitas ML15351A2632015-12-0808 December 2015 Official Exhibit - SHN-019-MA-CM01 - Statement of Qualifications of Erwin T. Prater ML15351A2642015-12-0808 December 2015 Official Exhibit - SHN-020-MA-CM01 - Statement of Qualifications of Louis Restrepo ML15351A2652015-12-0808 December 2015 Official Exhibit - SHN-021-MA-CM01 - Statement of Qualifications of Eric N. Van Abel ML15351A2782015-12-0808 December 2015 Official Exhibit - SHN-011-MA-CM01 - Statement of Qualifications of Timothy P. Krause ML15351A2912015-12-0808 December 2015 Official Exhibit - NRC-010-MA-CM01 - Staff Presentation Slides - Overview (December 8, 2015) ML15351A2922015-12-0808 December 2015 Official Exhibit - NRC-011-MA-CM01 - Staff Presentation Slides - Safety Panel 1( December 8, 2015) ML15351A2932015-12-0808 December 2015 Official Exhibit - NRC-013-MA-CM01 - Staff Presentation Slides - Environmental Panel (December 8, 2015) ML15351A2852015-12-0808 December 2015 Official Exhibit - SHN-029-MA-CM01 - Shine Presentation Slides: Environmental Panel ML15351A2662015-12-0808 December 2015 Official Exhibit - SHN-022-MA-CM01 - Statement of Qualifications of George F. Vandergrift ML15351A2802015-12-0808 December 2015 Official Exhibit - SHN-013-MA-CM01 - Statement of Qualifications of C. Michael Launi ML15351A2792015-12-0808 December 2015 Official Exhibit - SHN-012-MA-CM01 - Statement of Qualifications of Thomas Krzewinski ML15351A2772015-12-0808 December 2015 Official Exhibit - SHN-010-MA-CM01 - Statement of Qualifications of Catherine Kolb ML15351A2752015-12-0808 December 2015 Official Exhibit - SHN-009-MA-CM01 - Statement of Qualifications of Alan Hull ML15351A2742015-12-0808 December 2015 Official Exhibit - SHN-008-MA-CM01 - Statement of Qualifications of William Hennessy ML15351A2732015-12-0808 December 2015 Official Exhibit - SHN-007-MA-CM01 - Statement of Qualifications of James Costedio ML15351A2722015-12-0808 December 2015 Official Exhibit - SHN-025-MA-CM01 - Statement of Qualifications of Steven L. Zander ML15351A2712015-12-0808 December 2015 Official Exhibit - SHN-024-MA-CM01 - Statement of Qualifications of Ernest Wright ML15351A2702015-12-0808 December 2015 Official Exhibit - SHN-006-MA-CM01 - Statement of Qualifications of Richard Vann Bynum ML15351A2692015-12-0808 December 2015 Official Exhibit - SHN-023-MA-CM01 - Statement of Qualifications of Tamela B. Wheeler ML15351A2522015-11-24024 November 2015 Official Exhibit - SHN-001-MA-CM01 - Applicant'S Pre-Filed Testimony of James Costedio for the Mandatory Hearing on Uncontested Issues for the Shine Medical Technologies, Inc. Medical Radioisotope Production Facility ML15351A2282015-11-17017 November 2015 Official Exhibit - NRC-003-MA-CM01 - Draft Record of Decision for Shine Medical Technologies, Inc. Construction Permit Application (November 17, 2015) ML15351A2312015-10-31031 October 2015 Official Exhibit - NRC-009-MA-CM01 - NUREG-2183, Final Environmental Impact Statement for the Construction Permit for the Shine Medical Radioisotope Production Facility (October 16, 2015) ML15351A2262015-10-22022 October 2015 Official Exhibit - NRC-001-MA-CM01 - SECY-15-0130, Staff Statement in Support of the Uncontested Hearing for Issuance of Construction Permit for the Shine Medical Technologies, Inc. Medical Radioisotope Production Facility (October 22, 2015 ML15351A2412015-09-16016 September 2015 Official Exhibit - NRC-006B-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - Updated General Information (September 16, 2015) ML15351A2442015-08-27027 August 2015 Official Exhibit - NRC-006E-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application, (Psar), Chapter 2, Figure 2.5-1 Through Figure 2.5-6 (August 27, 2015) ML15351A2432015-08-27027 August 2015 Official Exhibit - NRC-006D-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - (Psar), Chapter 2, Figure 2.4-1 Through Figure 2.4-11 (August 27, 2015) ML15351A2452015-08-27027 August 2015 Official Exhibit - NRC-006N-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - Environmental Report, Chapter 19 Figure 19.3.4-1 to Chapter 19 Figure 19.3.4-8 (August 27, 2015) ML15351A2392015-08-27027 August 2015 Official Exhibit - NRC-006M-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - Environmental Report, (PSAR) Chapter 19, Figure 19.3.3-1 Through Figure 19.3.3-7 (August 27, 2015) ML15351A2462015-08-27027 August 2015 Official Exhibit - NRC-006O-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application, Environmental Report, (PSAR) Chapter 19 Figure 19.3.5-1 Through Figure 19.3.8-2 (August 27, 2015) ML15351A2352015-08-27027 August 2015 Official Exhibit - NRC-006K-MA-CM01 - Shine Medical Technologies, Inc., Construction Permit Application - Environmental Report, (PSAR) Chapter 19 Figure 19.3.1-7 Through Figure 19.3.1-9 (August 27, 2015) 2015-09-16
[Table view] |
Text
United States Nuclear Regulatory Commission Official Hearing Exhibit In the Matter of: SHINE MEDICAL TECHNOLOGIES, INC.
(Medical Radioisotope Production Facility)
Commission Mandatory Hearing Exhibit SHN-023 Docket #: 05000608 Exhibit #: SHN-023-MA-CM01 Identified: 12/15/2015 Admitted: 12/15/2015 Withdrawn:
Rejected: Stricken:
Other:
Tamela B. Wheeler Consulting Engineer Energy (Nuclear)
Profile Key experience Profession Mrs. Wheeler has over 20 years of Safety Basis Documentation Nuclear Safety experience in the nuclear industry supporting safety analysis and Hazards Analysis Work history radiological protection, providing Radiation Protection 2014 Joined Atkins support at a number of U.S.
Department of Energy (DOE) facilities, Quality Assurance 2009 - 2014 Nuclear Safety at three U.S. Nuclear Regulatory Certified Health Physicist Associates Commission (NRC) licensed nuclear Years with other firms:14 fuel and uranium hexafluoride facilities, and for two National Aeronautics Qualifications Space Administration (NASA) space missions and one NASA testing facility. M.S., Health Physics, Georgia Institute Ms. Wheeler is skilled in of Technology, 1994 facility/process hazard analysis, safety B.S., Physics, Valdosta State analysis and reporting, licensing, and University, 1993 risk assessment. In the area of radiation protection, she has supported Clearance dose assessments, environmental monitoring, radionuclide transport DOE Q (Active) modeling, and radiation work planning.
Experience Atkins [2009 Present] Consulting Engineer - Safety basis analyst - hazards identification, categorization and analysis; accident initiator identification, sequence development and consequence analysis for unmitigated / mitigated chemical and radiological releases; identification and application of countermeasure and controls; preparation of safety basis documentation.
Nevada National Security Site (NNSS), Los Alamos National Laboratory (LANL), and Idaho National Laboratory (INL)
- currently supporting DOE safety analysis activities for the NNSS. Specific tasks include dispersion analysis, hazards analysis, and consequence analysis utilizing such computational tools as MACCS2, POSTMAX, and GENII2 dispersion codes. Use of the computational tools also required Quality Assurance testing and documentation. She has also assisted in the preparation of gap analyses based on DOE-STD-3009-2014 for selected facilities at NNSS.
International Isotopes Fluorine Products (IIFP), Inc. - provided licensing support, safety analysis, and environmental assessment preparation for a a first-of-its-kind depleted uranium de-conversion facility and the first licensed source material facility to implement a full-integrated safety analysis, consistent with requirements of Part 70, Subpart H of NRC regulations.
SHINE Medical Isotopes, Inc. - provided safety analysis and environmental assessment support for the licensing effort.
Specific tasks included accident analysis and preparation of a normal operations dose assessment utilizing the GENII2 code.
Exhibit SHN-023 Statement of Qualifications of Tamela B. Wheeler.docxe
United States Nuclear Regulatory Commission Official Hearing Exhibit In the Matter of: SHINE MEDICAL TECHNOLOGIES, INC.
(Medical Radioisotope Production Facility)
Commission Mandatory Hearing Exhibit SHN-023 Docket #: 05000608 Exhibit #: SHN-023-MA-CM01 Identified: 12/15/2015 Admitted: 12/15/2015 Withdrawn:
Rejected: Stricken:
Other:
Tamela B. Wheeler Consulting Engineer Energy (Nuclear)
Profile Key experience Profession Mrs. Wheeler has over 20 years of Safety Basis Documentation Nuclear Safety experience in the nuclear industry supporting safety analysis and Hazards Analysis Work history radiological protection, providing Radiation Protection 2014 Joined Atkins support at a number of U.S.
Department of Energy (DOE) facilities, Quality Assurance 2009 - 2014 Nuclear Safety at three U.S. Nuclear Regulatory Certified Health Physicist Associates Commission (NRC) licensed nuclear Years with other firms:14 fuel and uranium hexafluoride facilities, and for two National Aeronautics Qualifications Space Administration (NASA) space missions and one NASA testing facility. M.S., Health Physics, Georgia Institute Ms. Wheeler is skilled in of Technology, 1994 facility/process hazard analysis, safety B.S., Physics, Valdosta State analysis and reporting, licensing, and University, 1993 risk assessment. In the area of radiation protection, she has supported Clearance dose assessments, environmental monitoring, radionuclide transport DOE Q (Active) modeling, and radiation work planning.
Experience Atkins [2009 Present] Consulting Engineer - Safety basis analyst - hazards identification, categorization and analysis; accident initiator identification, sequence development and consequence analysis for unmitigated / mitigated chemical and radiological releases; identification and application of countermeasure and controls; preparation of safety basis documentation.
Nevada National Security Site (NNSS), Los Alamos National Laboratory (LANL), and Idaho National Laboratory (INL)
- currently supporting DOE safety analysis activities for the NNSS. Specific tasks include dispersion analysis, hazards analysis, and consequence analysis utilizing such computational tools as MACCS2, POSTMAX, and GENII2 dispersion codes. Use of the computational tools also required Quality Assurance testing and documentation. She has also assisted in the preparation of gap analyses based on DOE-STD-3009-2014 for selected facilities at NNSS.
International Isotopes Fluorine Products (IIFP), Inc. - provided licensing support, safety analysis, and environmental assessment preparation for a a first-of-its-kind depleted uranium de-conversion facility and the first licensed source material facility to implement a full-integrated safety analysis, consistent with requirements of Part 70, Subpart H of NRC regulations.
SHINE Medical Isotopes, Inc. - provided safety analysis and environmental assessment support for the licensing effort.
Specific tasks included accident analysis and preparation of a normal operations dose assessment utilizing the GENII2 code.
Exhibit SHN-023 Statement of Qualifications of Tamela B. Wheeler.docxe